600624 Stock Overview
Operates in software development, biomedicine, real estate, and other businesses. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Shanghai Fudan Forward S&T Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.13 |
| 52 Week High | CN¥7.04 |
| 52 Week Low | CN¥2.76 |
| Beta | 0.53 |
| 11 Month Change | 27.44% |
| 3 Month Change | 118.15% |
| 1 Year Change | 1.83% |
| 33 Year Change | -4.67% |
| 5 Year Change | -23.38% |
| Change since IPO | -27.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600624 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 22.6% | 0.3% | -0.6% |
| 1Y | 1.8% | -7.9% | 3.2% |
Return vs Industry: 600624 exceeded the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 600624 matched the CN Market which returned 2.8% over the past year.
Price Volatility
| 600624 volatility | |
|---|---|
| 600624 Average Weekly Movement | 12.1% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600624's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 600624's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,363 | n/a | www.forwardgroup.com |
Shanghai Fudan Forward S&T Co., Ltd operates in software development, biomedicine, real estate, and other businesses. The company develops and exports software to Japan; and researches, develops, produces, and sells chemical drugs, Chinese patent medicines, freeze-dried powder injections, and solid preparations, as well as chemical raw materials, digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory system drugs, and traditional and modern Chinese medicines. It is also involved in the development of high-tech parks; and development, production, and sale of uninterruptible power supplies and lead-acid batteries, as well as professional agent of car audio brand.
Shanghai Fudan Forward S&T Co., Ltd Fundamentals Summary
| 600624 fundamental statistics | |
|---|---|
| Market cap | CN¥4.16b |
| Earnings (TTM) | -CN¥33.16m |
| Revenue (TTM) | CN¥638.98m |
6.5x
P/S Ratio-125.6x
P/E RatioIs 600624 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600624 income statement (TTM) | |
|---|---|
| Revenue | CN¥638.98m |
| Cost of Revenue | CN¥399.12m |
| Gross Profit | CN¥239.87m |
| Other Expenses | CN¥273.03m |
| Earnings | -CN¥33.16m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.049 |
| Gross Margin | 37.54% |
| Net Profit Margin | -5.19% |
| Debt/Equity Ratio | 47.0% |
How did 600624 perform over the long term?
See historical performance and comparison